Page last updated: 2024-09-05

latrepirdine and n(g)-aminoarginine

latrepirdine has been researched along with n(g)-aminoarginine in 1 studies

Compound Research Comparison

Studies (latrepirdine)	Trials (latrepirdine)	Recent Studies (post-2010) (latrepirdine)	Studies (n(g)-aminoarginine)	Trials (n(g)-aminoarginine)	Recent Studies (post-2010) (n(g)-aminoarginine)
126	7	59	21	1	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC	1

Reviews

1 review(s) available for latrepirdine and n(g)-aminoarginine

Article	Year
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers. Journal of medicinal chemistry, 2013, Apr-25, Volume: 56, Issue:8 Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate	2013

Article

Year

Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Journal of medicinal chemistry, 2013, Apr-25, Volume: 56, Issue:8

Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate

2013